Drug treatment reduces gout flares in clinical study
Can't see this email? View it online
   
  November 20, 2017  
  Gout  
  The latest Gout news from News Medical  
 Drug treatment reduces gout flares in clinical studyDrug treatment reduces gout flares in clinical study
 
As reported in the journal Arthritis & Rheumatology, the drug febuxostat reduced gout flares in a double-blind, placebo-controlled study of 314 adults with early gout.
 
 
 Kidney Stone ResearchKidney Stone Research
 
The incidence of kidney stone formation in pediatric patients is increasing at a rate of about 5–10% every year. Kidney stones are linked with higher risk of heart disease, hypertension, chronic kidney disease, and reduced amount of minerals in the bones. Many young patients being diagnosed with kidney stones is a matter of great concern.
 
   Causes of Ureteric CalculiCauses of Ureteric Calculi
 
Ureterolithiasis or ureteric calculi are stones that form in or travel down to the ureters, which are the slender muscular tubes that connect the kidneys to the urinary bladder. These tubes are physiologically constricted at 3 points along their lengths, namely at the ureteropelvic junction, entry into the pelvis as they cross the bifurcation of the common iliac artery and the ureterovesical junction.
 
 Hyperhidrosis Prognosis and Epidemiology
 
Hyperhidrosis Prognosis and EpidemiologyHyperhidrosis refers to excessive sweating that does not necessarily occur in response to the body becoming overheated by exercise or a hot environment, for example. Although the condition does not pose any significant health risk, it can disrupt daily activities, causing embarrassment, stress, and sometimes even depression.
 
 
 Online consultation via mobile app reduces costs and delays for rheumatic disease patients
 
Online consultation via mobile app reduces costs and delays for rheumatic disease patientsResearchers in China have developed a new online consultation tool for rheumatic disease patients, which may strengthen the interaction between doctors and patients and lead to more efficient management of chronic illness, according to new research findings presented this week at the 2017 ACR/ARHP Annual Meeting in San Diego.